Gilead Sciences, Inc.
MCL-1 INHIBITORS
Last updated:
Abstract:
The present disclosure generally relates to compounds and pharmaceutical compositions that may be used in methods of treating cancer.
Status:
Application
Type:
Utility
Filling date:
13 May 2019
Issue date:
21 Nov 2019